recommendations, The coronavirus ANA CAROLINA MORAES GOMES DE SOUZAdisease 2019 (COVID-19) pandemic has significantly impacted morbidity and mortality worldwide. Unilateral axillary lymphadenopathy induced by the COVID-19 vaccine is particularly relevant in women with breast cancer, with a predilection for metastasis to the axillary lymph nodes. Clinicians, radiologists, and patients may be concerned about COVID-19 vaccine-induced unilateral axillary lymphadenopathy because it may be a sign of breast cancer metastasis, leading to a diagnostic conundrum over whether to recommend a biopsy or short-term follow-up. This literature review aims to assess the best available evidence of axillary lymphadenopathy after COVID-19 vaccination. Recognizing COVID-19 vaccine-induced unilateral axillary lymphadenopathy as a potential differential diagnosis and making efforts to investigate the patient's vaccination history are crucial to avoid overestimating the burden of axillary disease and making appropriate therapeutic .; NOSE, ANDRE LUIS YAMAMOTO; LOPES, PATRICK DE ABREU CUNHA

18-Abr-2022

★★★★★ (0)